- •Amiodarone significantly improves survival to hospital admission.
- •Amiodarone does not improve survival to hospital discharge.
- •Amiodarone does not improve neurological outcome.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Global incidences of out-of-hospital cardiac arrest and survival rates: systematic review of 67 prospective studies.Resuscitation. 2010; 81: 1479-1487
- Quality management in resuscitation—towards a European cardiac arrest registry (EuReCa).Resuscitation. 2011; 82: 989-994
- Epidemiology and management of cardiac arrest: what registries are revealing.Best Pract. Res. Clin. Anaesthesiol. 2013; 27: 293-306
- Heart disease and stroke statistics—2014 update: a report from the American Heart Association.Circulation. 2014; 129: e28-e292
- National initiatives to improve outcomes from out-of-hospital cardiac arrest in England.Emerg Med J. 2016 Jul; 33: 448-451
- Part 5: adult basic life support and cardiopulmonary resuscitation quality: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care.Circulation. 2015; 132: S414-S435
- Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis.Circ. Cardiovasc. Qual. Outcomes. 2010; 3: 63-81
- Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest.JAMA. 2013; 310: 1377-1384
- Factors modifying the effect of bystander cardiopulmonary resuscitation on survival in out-of-hospital cardiac arrest patients in Sweden.Eur. Heart J. 2001; 22: 511-519
- Bystander initiated actions in out-of-hospital cardiopulmonary resuscitation: results from the Amsterdam Resuscitation Study (ARRESUST).Resuscitation. 2001; 50: 273-279
- Continuous improvements in “chain of survival” increased survival after out-of-hospital cardiac arrests: a large-scale population-based study.Circulation. 2009; 119: 728-734
- European Resuscitation Council guidelines for resuscitation 2015: section 3. Adult advanced life support.Resuscitation. 2015; 95: 100-147
- Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care.Circulation. 2015; 132: S444-S464
- Oral amiodarone: historical overview and development.Pharmacotherapy. 1998; 18: 121S-126S
- Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.N. Engl. J. Med. 2002; 346: 884-890
- Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.N. Engl. J. Med. 1999; 341: 871-878
- Antiarrhythmia drugs for cardiac arrest: a systemic review and meta-analysis.Crit. Care. 2013; 17: R173
- The “Code Drugs in Cardiac Arrest”—the use of cardioactive medications in cardiac arrest resuscitation.Am. J. Emerg. Med. 2012; 30: 811-818
- The use of antiarrhythmic drugs for adult cardiac arrest: a systematic review.Resuscitation. 2011; 82: 665-670
- Prognostication after cardiac arrest.Curr. Opin. Crit. Care. 2014; 20: 280-286
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.BMJ. 2011; 343: d5928
- Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest.N. Engl. J. Med. 2016; 374: 1711-1722
- Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients.J. Cardiovasc. Pharmacol. 2010; 55: 391-398
- The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest.Acta Anaesthesiol. Scand. 2004; 48: 582-587
- Nifekalant hydrochloride and amiodarone hydrochloride result in similar improvements for 24-hour survival in cardiopulmonary arrest patients: the SOS-KANTO 2012 study.J. Cardiovasc. Pharmacol. 2015; 66: 600-609
- Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.Crit. Care Med. 2006; 34: 1617-1623
- Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.Resuscitation. 2014; 85: 381-386
- Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation.J. Anesth. 2014; 28: 587-592
- The use of amiodarone for in-hospital cardiac arrest at two tertiary care centres.Can. J. Cardiol. 2006; 22: 199-202
- GRADE guidelines: 7. Rating the quality of evidence—inconsistency.J. Clin. Epidemiol. 2011; 64: 1294-1302
- Nifekalant in the treatment of life-threatening ventricular tachyarrhythmias.World J. Cardiol. 2011; 3: 169-176